Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma

Abstract Background This retrospective analysis of data from clinical trials in metastatic urothelial carcinoma (mUC) was conducted to determine baseline patient characteristics associated with long-term survival (LTS) following treatment with immune checkpoint inhibitors. Methods Data for this anal...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Marie Alt, Carlos Stecca, Yian Lin, Gbenga Kazeem, Erik T. Goluboff, Srikala S. Sridhar
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2023-09-01
Schriftenreihe:	BMC Cancer
Schlagworte:	Durvalumab Immune checkpoint inhibitor Long-term survival Multivariable analysis Predictive factors Univariable analysis
Online-Zugang:	https://doi.org/10.1186/s12885-023-11380-6
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!